Next-generation sequencing of urologic cancers: next is now.
The exomes/genomes of a few hundred kidney, bladder, and prostate tumours have been sequenced. This sequencing has unveiled new genes that are altered and new opportunities for tumour subclassification, prediction of outcome, and therapy. These opportunities will soon become realities.